retatrutide clinical trials latest New Phase 3 data just dropped ๐ Eli Lilly's trial reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats ๐๐ฅ๐ฒ๐๐ฎ๐๐ฟ๐๐๐ถ๐ฑ๐ฒ'๐ ๐จ๐ป๐ฒ๐ ๐ฝ๐ฒ๐ฐ๐๐ฒ๐ฑ ๐ฆ๐ถ๐ฑ๐ฒ ๐๐ณ๐ณ๐ฒ๐ฐ๐: ๐ช๐ต๐ฎ๐
Description
Using the share and save feature The calculator generates a shareable link that preserves your current inputs
The decrease in HbA1c caused by semaglutide is accompanied by a reduction in body weight, which is unique to semaglutide as an antidiabetic medication
Medical providers dont prescribe semaglutide to anyone who asks
This precautionary measure protects patients from potentially serious complications, including aspiration pneumonia
IGF, insulin-like growth factor
2024;22(6):1226-37 e14
